Is glutathione IV therapy safe for everyone
doi:10.2174/1875044301205010047 [25] Ueno PM, Ori RB, Maier EA, et al
Persistent postCOVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium
Common reported effects in clinical use include mild injection site reactions with subcutaneous administration, occasional digestive changes when taken orally, and rare reports of fatigue or dizziness
Rather than manipulating individual pathways in isolation, effective intervention will likely require coordinated, context-dependent modulation of chaperones, autophagy, UPS activity, and ER stress responses